- 专利标题： GLUCOSIDE DERIVATIVE THAT ACTS AS SGLT1 INHIBITOR AND APPLICATION THEREOF
-
申请号： US17599308申请日： 2020-03-30
-
公开(公告)号： US20220153772A1公开(公告)日： 2022-05-19
- 发明人: Yi LI , Tao YU , Qinghua MAO , Chengde WU , Shuhui CHEN
- 申请人： MEDSHINE DISCOVERY INC.
- 申请人地址： CN Nanjing, Jiangsu
- 专利权人： MEDSHINE DISCOVERY INC.
- 当前专利权人： MEDSHINE DISCOVERY INC.
- 当前专利权人地址： CN Nanjing, Jiangsu
- 优先权： CN201910251853.5 20190329,CN201911104949.5 20191113,CN202010105251.1 20200220
- 国际申请： PCT/CN2020/082007 WO 20200330
- 主分类号： C07H15/26
- IPC分类号： C07H15/26 ; A61P3/10 ; A61P3/04
摘要：
A glucoside derivative that acts as an SGLT1 inhibitor and an application thereof in the preparation of a drug for SGLT1 related diseases. Specifically disclosed is a compound represented by formula (II), a tautomer thereof or a pharmaceutically acceptable composition thereof.
信息查询
